Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

Rizzo,

If you think about what we learned at the R&R conference and this loan, it becomes obvious that they are not taking anything less then top dollar. Getting these trials going first brings in more money. $1m now, gets you $50m more later.m Remember the value accretion curve.? Good times.


Nasrat has noted the superiority, simplicity of the tech and lets not forget he was involved in other competing techs at Actavis and Alpharma. He came to Elite with a purpose, and a pocketful of shares.

The science here is straightforward as the Chairman likes to say and it is the same concept as Embeda and ALO-02 but far more robust and modular.